Phospholipids
- Name
- Phospholipids
- Accession Number
- DBCAT001467
- Description
Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system.
- ATC Classification
- Drugs
Drug Drug Description Omega-3 fatty acids An ingredient found in a variety of supplements and vitamins. Calcium glycerophosphate An medication used to treat low levels of phosphate or calcium, as well as an ingredient in dental products to prevent dental caries. Phosphatidyl serine A nutrient used in some supplement products. 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine Not Available Glycerol 2-phosphate Not Available Platelet Activating Factor Not Available Lysophosphatidylglycerol Not Available sn-glycero-3-phosphoethanolamine Not Available Cadaverine Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine. Indole-3-Glycerol Phosphate Not Available Phosphatidylethanolamine Not Available L-Dilinoleoyllecithin Not Available Choline alfoscerate A natural choline that is used to manage declining cognitive function associated with neurodegenerative and vascular diseases. Lucinactant Intended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. ETC-588 Investigated for use/treatment in atherosclerosis, coronary artery disease, and vascular diseases. Colfosceril palmitate A pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. Sodium glycerophosphate A medication used to treat hypophosphatemia. DL-dimyristoylphosphatidylcholine DL-dimyristoylphosphatidylcholine is not an active pharmaceutical agent and has no indication. DL-dimyristoylphosphatidylglycerol DL-dimyristoylphosphatidylglycerol is not an considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indications. Mifamurtide A muramyl dipeptide derivative used to treat high grade, resectable, non-metastatic osteosarcoma after surgical resection. 1,2-Distearoyllecithin Not Annotated VB-201 VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis). Lecithin Fatty substances commonly found in nutritional supplements. Iopofosine I-131 Iopofosine I-131 (NM-404 I-131) is under investigation in clinical trial NCT01495663 (Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned). 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine Not Annotated CHF5633 CHF5633 is a fully synthetic pulmonary surfactant preparation comprising DPPC (dipalmitoylphosphatidylcholine), POPG Na (palmitoyl‐oleoyl‐phosphatidylglycerol sodium), a synthetic SP-C analogue, and a synthetic SP-B analogue. - Drugs & Drug Targets